Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
64 /100
HIGH RISK
Score updated Oct 13, 2026

LIXT — Lixte Biotechnology Holdings, Inc. Dilution Risk Tracker

Track LIXT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LIXT — Get alerts when the score changes →

As of October 13, 2026, Lixte Biotechnology Holdings, Inc. (LIXT) has a DilutionWatch DilutionScore of 64/100, rated HIGH dilution risk. Lixte Biotechnology Holdings, Inc. has a market capitalization of $77.39M, 16.10M shares outstanding, 14 institutional holders tracked. Stored dilution-related fields include 3.61M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
35
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
📜 Warrant Exercise model 40%
• Significant warrants: 22% of shares outstanding
• Elevated warrant risk score (70/100)
🔄 Reverse Split model est. 15%
• 52-week low $0.64 has breached $1
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔔 Track LIXT — Get forecast alerts →

Market Data

Market Cap$77.39M
Shares Outstanding16.10M
Float11.11M
Cash$3.41M
Debt$1.03M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore64/100DilutionWatch score record
Shares Outstanding16.10MVerified float table or market cache
Public Float11.11MVerified float table or market cache
Market Cap$77.39MMarket data cache
Cash Runway9.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants3.61MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 1.6% shares (2026Q1 vs prior)
14 institutional holders · 782.0K shares
#1 SCOTIA CAPITAL INC. 283.2K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 99.0K shares
#3 RENAISSANCE TECHNOLOGIES LLC 93.0K shares
+ 11 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
xbrl XBRL CONVERTIBLE 2026-08-14
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LIXT Dilution Snapshot

Lixte Biotechnology Holdings, Inc. (LIXT) has a DilutionScore of 64/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LIXT's DilutionScore is currently 64/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 54/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202664/100HIGH13 days
Aug 22 – Sep 30, 202654/100HIGH40 days
Aug 14 – Aug 21, 202656/100HIGH7 days
Jul 16 – Aug 13, 202652/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LIXT shares outstanding have decreased 0.0% from 11.62M (Apr 2026) to 11.62M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 27, 202611.62M11.11M▼ 3.89%
Apr 20, 202611.62M11.56M▼ 0.43%
Apr 11, 202611.62M11.61M▲ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LIXT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LIXT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LIXT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LIXT
LIXT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.